바이오인

 The NHS as a Driver for Growth
 
 
The 21^st Century is bringing a revolution in the life sciences, engineering and information technology. This will in turn transform healthcare. Meanwhile the pharmaceutical industry is facing unprecedented challenges, with rising costs of research and development and the future loss of income as many important drugs come to the end of their patented protection.
 
The UK has immense strengths, both in basic research in these areas and in the professionalism and commitment within the NHS. For example, it is a world leader in the science of genomics and genetics, which have the potential to revolutionise medical practice and it has a proud history in the development of medical imaging technologies, but it has been weaker in the uptake and application of these technologies.